Halotestin Beligas: Compound Profile
Halotestin Beligas is a 17α-methylated anabolic androgenic steroid containing fluoxymesterone, recognised for its exceptional androgenic potency in laboratory research. This compound represents one of the most androgenically active steroids available for scientific investigation, with researchers examining its unique molecular structure and tissue-selective effects. Studies at Stroid UK Shop investigate fluoxymesterone’s distinctive 11β-hydroxy modification, which contributes to its remarkable androgenic activity profile compared to testosterone derivatives.
Laboratory investigations examine this compound’s resistance to aromatisation, making it valuable for researchers studying androgen receptor interactions without estrogenic interference. The methylation at the C17 position provides oral bioavailability in research models, though this modification significantly impacts hepatic enzyme systems. Research teams studying comparative steroid pharmacology utilise this compound alongside other fluoxymesterone preparations to understand structure-activity relationships in androgenic steroid research.
Scientific Applications
Research applications focus on fluoxymesterone’s unique position within the anabolic steroid classification, demonstrating minimal anabolic activity relative to its profound androgenic effects. Laboratory studies examine this compound’s interaction with androgen receptors in various tissue types, particularly investigating its selectivity patterns across different organ systems. Comparative research evaluates fluoxymesterone against other research compounds available in SARM collections to understand receptor binding specificity and downstream signalling pathways.
Advanced research protocols investigate the compound’s hepatotoxicity profile, examining cytochrome P450 enzyme interactions and metabolic clearance pathways. Studies utilise sophisticated analytical techniques to evaluate fluoxymesterone’s biotransformation products and their biological activities. Researchers also examine this compound’s effects on protein synthesis pathways, comparing its mechanisms to those observed with research peptides and growth factor modulators in cellular models.
Specifications
| Parameter | Value |
|---|---|
| Active Compound | Fluoxymesterone |
| CAS Number | 76-43-7 |
| Molecular Formula | C₂₀H₂₉FO₃ |
| Molecular Weight | 336.4 g/mol |
| Manufacturer | Beligas |
| Form | Oral preparation |
| Storage | Room temperature, dry |
| Purity | Verify with supplier |
Research Compliance
This research chemical is intended exclusively for in-vitro laboratory investigations and analytical reference purposes. Not approved for human consumption, therapeutic applications, or veterinary use. Researchers must maintain appropriate safety protocols and documentation when handling this compound. Institutional oversight and ethical approval may be required for certain research applications involving androgenic steroids.
